Metabolic disorders, while primarily endocrine in nature, can have significant psychiatric implications. From mood disturbances due to thyroid disorders to cognitive challenges in diabetes, understanding the broader impact is vital. The Journal of Clinical Psychiatry provides insights into the psychiatric aspects of metabolic disorders, emphasizing evidence-based therapeutic approaches. Our expert editors ensure content is actionable and holistic, aiding psychiatrists in offering comprehensive care.
Metabolic Disorders
Page 3
Recently published articles about Metabolic Disorders
Clinical and Practical Psychopharmacology
Cardiometabolic Risks in Schizophrenia and Directions for Intervention, Part 3
September 28, 2016
Patients with schizophrenia have increased rates of many cardiometabolic risk factors. Chittaranjan Andrade, MD, takes a look at the impact of pharmacological interventions, such as metformin, topiramate, and aripiprazole,...
Clinical and Practical Psychopharmacology
Cardiometabolic Risks in Schizophrenia and Directions for Intervention, Part 2
August 24, 2016
Patients with schizophrenia have increased rates of many cardiometabolic risk factors. In the second in a 2-part series, Chittaranjan Andrade, MD, looks at the impact of nonpharmacological interventions, such...
Article
Aripiprazole Partial Agonism at 5-HT2C: A Comparison of Weight Gain Associated With Aripiprazole Adjunctive to Antidepressants With High Versus Low Serotonergic Activities
October 18, 2012
Aripiprazole is a partial agonist at several receptor sites, one of which is 5-HT2C, which has been associated with increased food intake. The authors of this study theorize that...
Article
Antipsychotic Adherence and Its Correlation to Health Outcomes for Chronic Comorbid Conditions
June 21, 2012
The authors of this study examine the relationship between adherence to antipsychotics and adherence to medications for cardiometabolic conditions (diabetes, hypertension, and hyperlipidemia) and subsequent health care utilization and...
